Form 4: Envista Holdings Corp: Executive Robert Befidi Reports Acquisition of Shares and Derivative Securities

Sentiment:

SEC Form 4 Filing


Robert Befidi, President of Diagnostics at Envista Holdings Corp, reports the acquisition of shares and derivative securities, including Restricted Stock Units, Performance Share Units, and Employee Stock Options.

Summary

  • On February 25, 2024, Robert Befidi, President of Diagnostics at Envista Holdings Corp, reported transactions involving the company's securities.
  • Befidi acquired 9,385 shares of common stock at $0 price.
  • Following the transaction, Befidi beneficially owns 43,245 shares of common stock.
  • He also acquired 17,260 Performance Share Units, which will vest based on the achievement of performance measures over a three-year period, with potential payout ranging from 0% to 200% of the reported amount.
  • Additionally, Befidi acquired 21,910 Employee Stock Options with an exercise price of $22.65, vesting ratably over three years, and expiring on February 25, 2034.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard SEC filing reporting transactions by an officer. The acquisition of shares and options could be interpreted as a positive sign, but it's a routine part of executive compensation.

Positives

  • The acquisition of shares and derivative securities by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The Performance Share Units will vest based on the achievement of identified performance measures over a three-year performance period, indicating a focus on future performance and growth.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Monitoring these transactions can provide insights into management's perspective on the company's value and future prospects.

Stakeholder Impact

  • The reported transactions may have a minor impact on shareholders' perception of the company, as insider transactions are often monitored for signals about management's confidence.

Key Dates

DateDescription
02/25/2024Date of the reported transactions, including acquisition of common stock, Performance Share Units, and Employee Stock Options.
02/25/2034Expiration date of the Employee Stock Options.
02/27/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.